Documented concern based on cited evidence — not a personalized safety check, not medical advice, and not a decision to combine or avoid. That decision belongs with your prescriber.
Documented concern — monitor and disclose
Clinically relevant documented concern. Disclose the supplement to your clinician and keep monitoring in place.
Mechanism and evidence
Case reports and cohort signals document spontaneous bleeding with ginkgo; on dual pathway antiplatelets the added risk is clinically relevant.
Evidence tier: case-cohort
The tier names the strongest cited study design. Some anchors studied the supplement on its own, or a related drug in the same class — in those pairs the grade rests on that evidence plus established pharmacology, as agreed with our medical reviewer.
What to discuss with your prescriber
- Do not start ginkgo on aspirin or clopidogrel without a doctor decision.
- Treat any unusual bleeding as urgent.
← All reviewed pairs for Antiplatelets (aspirin, clopidogrel)